Docosahexaenoic acid (DHA): A modulator of microglia activity and dendritic spine morphology

Journal of Neuroinflammation

Volumn 12, Issue 1, 2015, Pages

  Chang, Philip ^a   Khatchadourian, Armen ^a   McKinney, Anne ^a   Maysinger, Dusica ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Dendritic spines; Docosahexaenoic acid; Lipid bodies; Microglia; Mitochondria; Neuroinflammation

Indexed keywords

AMPA RECEPTOR; DOCOSAHEXAENOIC ACID; LIPOPOLYSACCHARIDE; NITRIC OXIDE; 5,5',6,6'-TETRACHLORO-1,1',3,3'-TETRAETHYLBENZIMIDAZOLOCARBOCYANINE; ADIPOPHILIN; BENZIMIDAZOLE DERIVATIVE; CARBOCYANINE; CYTOCHROME C; FAT DROPLET; MEMBRANE PROTEIN; POLYSACCHARIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL DENSITY; CELL FUNCTION; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC SPINE; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPAL CA1 REGION; INFLAMMATION; MICROGLIA; MINIATURE ENDPLATE POTENTIAL; NERVE CELL; NONHUMAN; PYRAMIDAL NERVE CELL; SLICE CULTURE; SYNAPSE; SYNAPTIC TRANSMISSION; ACTION POTENTIAL; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IN VITRO STUDY; METABOLISM; MOUSE; NEWBORN; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY; TRANSGENIC MOUSE;

ACTION POTENTIALS; ANIMALS; ANIMALS, NEWBORN; BENZIMIDAZOLES; CARBOCYANINES; CELLS, CULTURED; CYTOCHROMES C; DENDRITIC SPINES; DOCOSAHEXAENOIC ACIDS; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IN VITRO TECHNIQUES; LIPID DROPLETS; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MICROGLIA; NEURONS; NITRIC OXIDE; ORGAN CULTURE TECHNIQUES; PERILIPIN-2; POLYSACCHARIDES;

EID: 84924217948     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/s12974-015-0244-5     Document Type: Article

References (83)

1. Salter Michael W, Beggs S. Sublime microglia: expanding roles for the guardians of the CNS. Cell. 2014;158:15-24.
2. Galland L. Diet and inflammation. Nutr Clin Pract. 2010;25:634-40.
3. Dinarello CA. Anti-inflammatory agents: present and future. Cell. 2010;140:935-50.
4. Raederstorff D, Pantze M, Bachmann H, Moser U. Anti-inflammatory properties of docosahexaenoic and eicosapentaenoic acids in phorbol-ester-induced mouse ear inflammation. Int Arch Allergy Immunol. 1996;111:284-90.
5. Hong S, Gronert K, Devchand PR, Moussignac R-L, Serhan CN. Novel docosatrienes and 17 s-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells: autocoids in anti-inflammation. J Biol Chem. 2003;278:14677-87.
6. Innis SM. Dietary (n-3) fatty acids and brain development. J Nutr. 2007;137:855-9.
7. Dyall SC, Michael-Titus AT. Neurological benefits of omega-3 fatty acids. Neuromolecular Med. 2008;10:219-35.
8. Hartmann T, van Wijk N, Wurtman RJ, Olde Rikkert MGM, Sijben JWC, Soininen H, et al. A nutritional approach to ameliorate altered phospholipid metabolism in Alzheimer's disease. J Alzheimer's Dis. 2014;41:715-7.
9. Cansev M, Wurtman RJ. Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils. Neuroscience. 2007;148:421-31.
10. Cole GM, Ma Q-L, Frautschy SA. Omega-3 fatty acids and dementia. Prostaglandins Leukot Essent Fatty Acids. 2009;81:213-21.
11. Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Moser A, Brockhurst RJ, et al. Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin a treatment. Arch Ophthalmol. 2004;122:1297-305.
12. Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA. 2010;304:1903-11.
13. Kettenmann H, Kirchhoff F, Verkhratsky A. Microglia: new roles for the synaptic stripper. Neuron. 2013;77:10-8.
14. Hughes V. Microglia: the constant gardeners. Nature. 2012;485:570-2.
15. Hughes MM, Field RH, Perry VH, Murray CL, Cunningham C. Microglia in the degenerating brain are capable of phagocytosis of beads and of apoptotic cells, but do not efficiently remove prpsc, even upon LPS stimulation. Glia. 2010;58:2017-30.
16. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci. 2005;8:752-8.
17. Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308:1314-8.
18. Tremblay M-È, Lowery RL, Majewska AK. Microglial interactions with synapses are modulated by visual experience. PLoS Biol. 2010;8:e1000527.
19. Wake H, Moorhouse AJ, Jinno S, Kohsaka S, Nabekura J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci. 2009;29:3974-80.
20. Paolicelli R, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, et al. Synaptic pruning by microglia is necessary for normal brain development. Science. 2011;333:1456-8.
21. Tremblay M-È, Stevens B, Sierra A, Wake H, Bessis A, Nimmerjahn A. The role of microglia in the healthy brain. J Neurosci. 2011;31:16064-9.
22. Nakamura Y, Si QS, Kataoka K. Lipopolysaccharide-induced microglial activation in culture: temporal profiles of morphological change and release of cytokines and nitric oxide. Neurosci Res. 1999;35:95-100.
23. Hanisch U-K. Microglia as a source and target of cytokines. Glia. 2002;40:140-55.
24. Hanisch U-K, Johnson TV, Kipnis J. Toll-like receptors: roles in neuroprotection? Trends Neurosci. 2008;31:176-82.
25. Martin S, Parton RG. Lipid droplets: a unified view of a dynamic organelle. Nat Rev Mol Cell Biol. 2006;7:373-8.
26. Farese RV, Walther TC. Lipid droplets finally get a little r-e-s-p-e-c-t. Cell. 2009;139:855-60.
27. Murphy S, Martin S, Parton RG. Lipid droplet-organelle interactions; sharing the fats. BBA - Mol Cell Biol L. 2009;1791:441-7.
28. Lecchi C, Invernizzi G, Agazzi A, Modina S, Sartorelli P, Savoini G, et al. Effects of EPA and DHA on lipid droplet accumulation and mRNA abundance of pat proteins in caprine monocytes. Res Vet Sci. 2013;94:246-51.
29. McKinney RA. Physiological roles of spine motility: development, plasticity and disorders. Biochem Soc Trans. 2005;33:1299-302.
30. McKinney RA. Excitatory amino acid involvement in dendritic spine formation, maintenance and remodelling. J Physiol. 2010;588:107-16.
31. McKinney RA, Thompson SM. Glutamate regulation of dendritic spine form and function. In: Squire LR, editor. Encyclopedia of neuroscience. Oxford: Academic; 2009. p. 905-11.
32. Colgan LA, Yasuda R. Plasticity of dendritic spines: subcompartmentalization of signaling. Annu Rev Physiol. 2014;76:365-85.
33. Sala C, Segal M. Dendritic spines: the locus of structural and functional plasticity. Physiol Rev. 2014;94:141-88.
34. Harris KM, Weinberg RJ. Ultrastructure of synapses in the mammalian brain. Cold Spring Harb Perspect Biol. 2012;4:1-30.
35. Matsuzaki M, Honkura N, Ellis-Davies GCR, Kasai H. Structural basis of long-term potentiation in single dendritic spines. Nature. 2004;429:761-6.
36. Bourne J, Harris KM. Do thin spines learn to be mushroom spines that remember? Curr Opin Neurobiol. 2007;17:381-6.
37. Rochefort NL, Konnerth A. Dendritic spines: from structure to in vivo function. Journal Article. 2012;13:699-708.
38. Lai K-O, Ip NY. Structural plasticity of dendritic spines: the underlying mechanisms and its dysregulation in brain disorders. BBA - Mol Basis Dis. 2013;1832:2257-63.
39. Pozueta J, Lefort R, Shelanski ML. Synaptic changes in Alzheimer's disease and its models. Neuroscience. 2013;251:51-65.
40. Nimchinsky EA, Sabatini BL, Svoboda K. Structures and function of dendritic spines. Annu Rev Physiol. 2002;64:313-53.
41. Gähwiler BH, Capogna M, Debanne D, McKinney RA, Thompson SM. Organotypic slice cultures: a technique has come of age. Trends Neurosci. 1997;20:471-7.
42. Chang PKY, Boridy S, McKinney RA, Maysinger D. Letrozole potentiates mitochondrial and dendritic spine impairments induced by β-amyloid. J Aging Res. 2013;2013:1-11.
43. Bulankina AV, Deggerich A, Wenzel D, Mutenda K, Wittmann JG, Rudolph MG, et al. TIP47 functions in the biogenesis of lipid droplets. J Cell Biol. 2009;185:641-55.
44. Imamura M, Inoguchi T, Ikuyama S, Taniguchi S, Kobayashi K, Nakashima N, et al. ADRP stimulates lipid accumulation and lipid droplet formation in murine fibroblasts. Am J Physiol Endocrinol Metab. 2002;283:E775-83.
45. Feingold KR, Kazemi MR, Magra AL, McDonald CM, Chui LG, Shigenaga JK, et al. ADRP/ADFP and Mal1 expression are increased in macrophages treated with tlr agonists. Atherosclerosis. 2010;209:81-8.
46. Khatchadourian A, Bourque SD, Richard VR, Titorenko VI, Maysinger D. Dynamics and regulation of lipid droplet formation in lipopolysaccharide (LPS)-stimulated microglia. BBA - Mol Cell Biol L. 2012;1821:607-17.
47. Jägerström S, Polesie S, Wickström Y, Johansson BR, Schröder HD, Højlund K, et al. Lipid droplets interact with mitochondria using Snap23. Cell Biol Int. 2009;33:934-40.
48. Goodman JM. The gregarious lipid droplet. J Biol Chem. 2008;283:28005-9.
49. Orr SK, Trépanier M-O, Bazinet RP. N-3 polyunsaturated fatty acids in animal models with neuroinflammation. Prostaglandins Leukot Essent Fatty Acids (PLEFA). 2013;88:97-103.
50. Aguzzi A, Barres BA, Bennett ML. Microglia: scapegoat, saboteur, or something else? Science. 2013;339:156-61.
51. Kettenmann H, Hanisch U-K, Noda M, Verkhratsky A. Physiology of microglia. Physiol Rev. 2011;91:461-553.
52. Goings GE, Kozlowski DA, Szele FG. Differential activation of microglia in neurogenic versus non-neurogenic regions of the forebrain. Glia. 2006;54:329-42.
53. Hanisch U-K, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci. 2007;10:1387-94.
54. Gurley C, Nichols J, Liu S, Phulwani NK, Esen N, Kielian T. Microglia and astrocyte activation by toll-like receptor ligands: modulation by PPAR- agonists. PPAR Res. 2008;2008:15.
55. Schafer DP, Lehrman EK, Stevens B. The "quad-partite" synapse: microglia-synapse interactions in the developing and mature cns. Glia. 2013;61:24-36.
56. Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R, et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron. 2012;74:691-705.
57. Stephan AH, Barres BA, Stevens B. The complement system: an unexpected role in synaptic pruning during development and disease. Annu Rev Neurosci. 2012;35:369-89.
58. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, et al. The classical complement cascade mediates CNS synapse elimination. Cell. 2007;131:1164-78.
59. Guo Y, Cordes KR, Farese RV, Walther TC. Lipid droplets at a glance. J Cell Sci. 2009;122:749-52.
60. Khatchadourian A, Maysinger D. Lipid droplets: their role in nanoparticle-induced oxidative stress. Mol Pharm. 2009;6:1125-37.
61. Yang H, Galea A, Sytnyk V, Crossley M. Controlling the size of lipid droplets: lipid and protein factors. Curr Opin Cell Biol. 2012;24:509-16.
62. Chen CT, Trepanier M-O, Hopperton KE, Domenichiello AF, Masoodi M, Bazinet RP. Inhibiting mitochondrial [beta]-oxidation selectively reduces levels of nonenzymatic oxidative polyunsaturated fatty acid metabolites in the brain. J Cereb Blood Flow Metab. 2014;34:376-9.
63. Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510:92-101.
64. Lafourcade M, Larrieu T, Mato S, Duffaud A, Sepers M, Matias I, et al. Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nat Neurosci. 2011;14:345-50.
65. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 2010;142:687-98.
66. Talukdar S, Olefsky JM, Osborn O. Targeting GPR120 and other fatty acid-sensing gpcrs ameliorates insulin resistance and inflammatory diseases. Trends Pharmacol Sci. 2011;32:543-50.
67. Calon F, Lim GP, Yang F, Morihara T, Teter B, Ubeda O, et al. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron. 2004;43:633-45.
68. Calon F, Lim GP, Morihara T, Yang F, Ubeda O, Salem N, et al. Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases nmda receptors in the brain of a transgenic mouse model of Alzheimer's disease. Eur J Neurosci. 2005;22:617-26.
69. Bazinet RP, Laye S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci. 2014;15:771-85.
70. Rao JS, Ertley RN, Lee HJ, DeMar Jr JC, Arnold JT, Rapoport SI, et al. N-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex bdnf via a p38 MAPK-dependent mechanism. Mol Psychiatry. 2006;12:36-46.
71. Bazan NG. Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr Opin Clin Nutr Metab Care. 2007;10:136-41.
72. Cole GM, Frautschy SA. DHA may prevent age-related dementia. J Nutr. 2010;140:869-74.
73. Picq M, Chen P, Perez M, Michaud M, Véricel E, Guichardant M, et al. DHA metabolism: targeting the brain and lipoxygenation. Mol Neurobiol. 2010;42:48-51.
74. Bibel M, Barde Y-A. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev. 2000;14:2919-37.
75. Wu A, Ying Z, Gomez-Pinilla F. Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J Neurotrauma. 2004;21:1457-67.
76. Zhao M, Zhou A, Xu L, Zhang X. The role of TLR4-mediated PTEN/PI3K/AKT/NF-κB signaling pathway in neuroinflammation in hippocampal neurons. Neuroscience. 2014;269:93-101.
77. Sheng Z-H, Cai Q. Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration. Nat Rev Neurosci. 2012;13:77-93.
78. Tyurina YY, Poloyac SM, Tyurin VA, Kapralov AA, Jiang J, Anthonymuthu TS, et al. Mitochondrial pathway for biosynthesis of lipid mediators. Nat Chem. 2014;6:542-52.
79. Flis VV, Daum G. Lipid transport between the endoplasmic reticulum and mitochondria. Cold Spring Harb Perspect Biol. 2013;5:1-22.
80. Cosentino K, García-Sáez AJ. Mitochondrial alterations in apoptosis. Chem Phys Lipids. 2014;181:62-75.
81. Ren M, Phoon CKL, Schlame M. Metabolism and function of mitochondrial cardiolipin. Prog Lipid Res. 2014;55:1-16.
82. Chu CT, Ji J, Dagda RK, Jiang JF, Tyurina YY, Kapralov AA, et al. Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells. Nat Cell Biol. 2013;15:1197-205.
83. Mapstone M, Cheema AK, Fiandaca MS, Zhong X, Mhyre TR, MacArthur LH, et al. Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med. 2014;20:415-8.